Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | AMGN | BMY | VRTX | GILD |
| Company | Acceleron Pharma | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 179.85 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 179.85 | 289.84 | 58.22 | 455.43 | 89.34 |
| Low | 177.06 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 178.75 | 288.23 | 57.97 | 447.22 | 89.16 |
| Change | -0.93 | +0.36 | +0.09 | -4.01 | +0.53 |
| % Change | -0.52% | +0.13% | +0.16% | -0.89% | +0.60% |
| Volume | 7,884,200 | 728,851 | 1,994,795 | 363,543 | 1,008,251 |
| 20-Day Average Volume | 1,302,050 | 2,777,740 | 12,115,782 | 1,286,034 | 7,370,567 |
| Previous Close | 179.68 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 307.40 | 55.91 | 479.12 | 90.86 |
| 20-Day Raw Stochastic | 84.01% | 26.36% | 67.21% | 3.99% | 24.10% |
| 20-Day Relative Strength | 70.12% | 36.15% | 60.29% | 40.28% | 52.29% |
| Weighted Alpha | +57.78 | +1.70 | +25.49 | +17.23 | +24.93 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | -2.19% since 11/14/24 | -0.79% since 11/14/24 | -7.41% since 11/14/24 | -3.19% since 11/14/24 |
| Low | 173.17 on 11/16/21 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 179.94 on 11/17/21 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -8.62% since 10/21/24 | +11.36% since 10/21/24 | -6.27% since 10/21/24 | +3.34% since 10/21/24 |
| Low | 172.25 on 10/20/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 179.94 on 11/17/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -12.06% since 08/21/24 | +19.82% since 08/21/24 | -7.82% since 08/21/24 | +18.69% since 08/21/24 |
| Low | 120.20 on 08/20/21 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 189.99 on 09/29/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | -8.07% since 05/21/24 | +37.31% since 05/21/24 | +1.38% since 05/21/24 | +32.52% since 05/21/24 |
| Low | 113.49 on 07/15/21 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 189.99 on 09/29/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 61,156 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 92,520,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -166,030,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 34,200,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -70,470,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.13 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/04/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |